The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi

Status unconfirmed

Conditions studied: Myocardial Ischemia

In brief

Research Questions: 1. Is there a significant difference between the causal repeat rate of myocardial perfusion studies for Tc99m tetrofosmin and Tc99m sestamibi? 2. Is there a significant difference in the causal repeat rate of myocardial perfusion studies for Tc99m tetrofosmin and Tc99m sestamibi if an independent technologist reviewer blinded to the radiopharmaceutical makes the decision to repeat the study? 3. Is there a significant difference in the quantitative diagnostic measures reported between the original and the acceptable repeated studies?

Key facts

Study ID

NCT01047150

Run by

Cardiac Imaging of Augusta

People needed

250

Starts

2010-01-01

Expected to finish

2010-02-01

Last updated by the study team

2010-01-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients receiving sestamibi MPI study or tetrofosmin MPI study

You may not qualify if…

• Thallium or dual isotope MPI study

Where it is running

• Cardiac Imaging of Augusta — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.